FF
FFR106080
Phase 3 small_molecule completed
Quick answer
FF for Rhinitis, Allergic, Perennial is a Phase 3 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Rhinitis, Allergic, Perennial
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed